Archive 2020 and earlier
Vifor Pharma licenses marketing rights to CCX168 in certain territories
Press release, Tuesday, 10 May 2016
Vifor Fresenius Medical Care Renal Pharma acquires marketing rights to RAYALDEE®
Press release, Monday, 9 May 2016
Annual General Meeting 2016 Galenica Ltd.
Press release, Thursday, 28 April 2016
Patiromer submitted to EMA to seek approval in the EU
Press release, Monday, 25 April 2016
Results 2015 of the Galenica Group
Press release, Monday, 14 March 2016
2015 sales of the Galenica Group
Press release, Thursday, 21 January 2016
Galenica plans to divide the Group in the 4th quarter of 2016
Press release, Tuesday, 1 December 2015
Kissei receives Japanese approval for P-TOL® (in the USA and Europe commercialized as Velphoro®)
Press release, Wednesday, 30 September 2015
Vifor Fresenius Medical Care Renal Pharma enters into partnership with Relypsa to commercialise Patiromer FOS
Press release, Tuesday, 11 August 2015
Galenica Group half-year results 2015
Press release, Tuesday, 11 August 2015
Galenica Santé: new strategic priorities and changes to the organisational structure
Press release, Thursday, 2 July 2015
Vifor Fresenius Medical Care Renal Pharma to expand its business activities
Press release, Thursday, 28 May 2015
Galenica and Roche enter into exclusive license agreement for the commercialisation of Mircera® in the US
Press release, Wednesday, 27 May 2015
2015 Annual General Meeting of Galenica Ltd.
Press release, Thursday, 7 May 2015
Measures to ensure strategy implementation
Press release, Monday, 13 April 2015
Results of the Galenica Group for 2014
Press release, Tuesday, 10 March 2015
Galenica Group sales 2014
Press release, Wednesday, 21 January 2015
Velphoro® receives EU Marketing Authorisation
Press release, Wednesday, 27 August 2014
Results of the Galenica Group for the first half of 2014
Press release, Tuesday, 12 August 2014
Galenica lays foundation for two listed, independent companies
Press release, Monday, 11 August 2014
Velphoro® (PA21) receives Positive CHMP Opinion
Press release, Friday, 27 June 2014
2014 Annual General Meeting of Galenica Ltd.
Press release, Thursday, 8 May 2014
Results of the Galenica Group 3013
Press release, Tuesday, 11 March 2014
Galenica posts solid sales growth for 2013 and confirms double-digit growth in profit
Press release, Tuesday, 21 January 2014
Contact
Galenica Ltd.
3027 Bern
Tel. +41 58 852 85 17
Mobile +41 79 371 77 24
Fax +41 58 852 85 58